Elanco executive joins Neurizon board as observer
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Neurizon Therapeutics Ltd (NUZ)
Neurizon Therapeutics Ltd stock price live, this page displays ASX NUZ stock exchange data. View the NUZ premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Neurizon Therapeutics Ltd real time stock price chart below.
What Is the Neurizon Therapeutics Ltd Stock Price Today?
The Neurizon Therapeutics Ltd stock price today is 0.057.
What Is the Stock Symbol for Neurizon Therapeutics Ltd?
The stock symbol for Neurizon Therapeutics Ltd is "NUZ."
What Stock Exchange Does Neurizon Therapeutics Ltd Trade On?
Neurizon Therapeutics Ltd is listed and trades on the Sydney stock exchange.
Is Neurizon Therapeutics Ltd a Good Stock to Buy?
Determining whether Neurizon Therapeutics Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NUZ quote. (ISIN: AU0000357261)
What Is the Neurizon Therapeutics Ltd Stock Price Today?
The Neurizon Therapeutics Ltd stock price today is 0.057.
What Is the Stock Symbol for Neurizon Therapeutics Ltd?
The stock symbol for Neurizon Therapeutics Ltd is "NUZ."
What Stock Exchange Does Neurizon Therapeutics Ltd Trade On?
Neurizon Therapeutics Ltd is listed and trades on the Sydney stock exchange.
Is Neurizon Therapeutics Ltd a Good Stock to Buy?
Determining whether Neurizon Therapeutics Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NUZ quote. (ISIN: AU0000357261)
0.057
+0.001(+1.79%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.056
0.057
52 wk Range
0.055
0.165
NUZ is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.0560.057
52 wk Range
0.0550.165
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
NUZ Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
0.200
Upside
+250.88%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 0.200
(+250.88% Upside)
Earnings
Latest Release
Feb 24, 2026
EPS / Forecast
-0.01 / --
Revenue / Forecast
5.97M / --
Compare NUZ to Peers and Sector
Metrics to compare | NUZ | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipNUZPeersSector | |
|---|---|---|---|---|
P/E Ratio | −4.1x | −8.9x | −0.4x | |
PEG Ratio | −0.09 | −0.01 | 0.00 | |
Price/Book | 3.5x | 3.3x | 2.6x | |
Price / LTM Sales | 2.5x | 17.6x | 3.1x | |
Upside (Analyst Target) | 250.9% | 263.6% | 48.2% | |
Fair Value Upside | Unlock | −2.7% | 6.5% | Unlock |
Neurizon Therapeutics Limited, a clinical stage biotechnology company, engages in the development of treatments for neurodegenerative diseases in Australia. Its lead candidate is NUZ-001, a small molecule drug designed to support cellular protein homeostasis which is evaluated in Regimen I of the Phase 2/3 HEALEY ALS platform trial for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company was formerly known as PharmAust Limited and changed its name to Neurizon Therapeutics Limited in October 2024. Neurizon Therapeutics Limited was incorporated in 2000 and is based in Melbourne, Australia.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Neurizon Therapeutics (NUZ) Stock Price Today?
The Neurizon Therapeutics stock price today is 0.057 AUD.
What Stock Exchange Does Neurizon Therapeutics Trade On?
Neurizon Therapeutics is listed and trades on the Sydney Stock Exchange.
What Is the Stock Symbol for Neurizon Therapeutics?
The stock symbol for Neurizon Therapeutics is "NUZ."
What Is the Neurizon Therapeutics Market Cap?
As of today, Neurizon Therapeutics market cap is 43.790M AUD.
What Is Neurizon Therapeutics's Earnings Per Share (TTM)?
The Neurizon Therapeutics EPS (TTM) is -0.018.
From a Technical Analysis Perspective, Is NUZ a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Neurizon Therapeutics Stock Split?
Neurizon Therapeutics has split 6 times.
How Many Employees Does Neurizon Therapeutics Have?
Neurizon Therapeutics has 4 employees.
What is the current trading status of Neurizon Therapeutics (NUZ)?
As of Aug 29, 2026, Neurizon Therapeutics (NUZ) is trading at a price of 0.057 AUD, with a previous close of 0.056 AUD. The stock has fluctuated within a day range of 0.056 AUD to 0.057 AUD, while its 52-week range spans from 0.055 AUD to 0.165 AUD.
What Is Neurizon Therapeutics (NUZ) Price Target According to Analysts?
The average 12-month price target for Neurizon Therapeutics is 0.200 AUD, with a high estimate of 0.2 AUD and a low estimate of 0.2 AUD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +250.88% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.